BioMedGPS, a leading provider of real-time data and analysis in the orthopedic, wound care and neuro therapies markets, is pleased to welcome Amanda Tracy into the role of Chief Commercial Officer. Joining the BioMedGPS leadership team, Ms. Tracy will be responsible for overseeing all sales and marketing initiatives for the company’s highly regarded SmartTRAK Business Intelligence platform.

Ms. Tracy brings with her over 22 years of experience in sales, marketing and business development in both the medical device and pharmaceutical industries. Along with the many relationships she has fostered within the industry, Ms. Tracy brings a unique understanding of the musculoskeletal clinical, regulatory and reimbursement landscapes and the value of integration with each. Prior to joining BioMedGPS, Ms. Tracy worked for 10 years at Musculoskeletal Clinical Regulatory Advisors (MCRA), where she attained the position of Vice President, Global Market Development and was responsible for growing MCRA’s revenues from $100K to $20 million.

“I am delighted to have such a high caliber and seasoned professional as Amanda Tracy lead our commercial efforts,” reports Sharon O’Reilly, President and CEO of BioMedGPS. “Amanda has the breadth of experience and proven expertise needed to bring BioMedGPS to the next level.” 

Irrespective of Market Challenges, Orthobiologics Remain Strong

While SmartTRAK saw a strong start in the beginning of the year, Orthobiologics didn’t see the typical Q2 bump. This trend was primarily driven by lower bone replacement revenues. Revenues from the sports medicine segments partially offset the bone replacement declines, with strong performances in Cartilage Replacement and Soft Tissue Augmentation.

Among the many topics covered in the full Q218 Ortho Market Recap are:

Baxter, Ethicon and Integra lead the way...

As reported in  SmartTRAK’s Financial Dashboard, the US market for Hemostats and Sealants grew +3.8% YoY in Q218, an increase from +3.1% growth rate overall in Q118. Fibrin sealants continue to lead the way with +7.2% YoY growth in Q218, and thrombin hemostats had a very good quarter with +7.2% growth YoY...

Among the many topics covered in the full Q218 Hemostats and Sealants Market Recap are:

• Ethicon Continues to Lead Hemostats and Sealants
• Thrombins Come Back In Hemostats
• Fibrin Continues To Shine In Sealants
• Q218 events in the US Hemostats and Sealants Market

Volume Up, Pricing Down, Overall Market Lower

Now that Q218 results are in, the US Joint Fluid market continued to experience downward pressure posting negative growth of -6.5% for the quarter and -4.0% YTD, according to SmartTRAK Financial Dashboard results ...

Cerapedics’ CEO Glen Kashuba and President and COO Jeff Marx, Ph.D. discuss the future of the bone graft substitutes and the uniqueness of i‑FACTOR Peptide Enhanced Bone Graft, a small peptide technology in an interview with Kim French, Sr. Analyst, SmartTRAK Orthbio.

A transcript of SmartTRAK's interview with Glen Kashuba and Jeff Marx is below, or click on the following video to listen to the interview.

With SmartTRAK, you will always be ahead of the competition.

We just launched SmartTRAK 3.0, the latest version of our premier Business Intelligence Data Platform in the Orthopedics, Wound Care and Neuro Therapies spaces.

It’s here! Cue the confetti. SmartTRAK 3.0 has officially launched today Monday, August 6! We couldn’t be more excited and we have our subscribers to thank.  Why our subscribers, you may ask?

Because our latest iteration of SmartTRAK was inspired by them.

For the past year, we at SmartTRAK have been talking with our subscribers to find out how we could better serve them.  ‘How can we make SmartTRAK even smarter?’ we asked. We learned that users wanted easier access to information and a better overall user experience.

Are you ready for faster, more intuitive business intelligence research experience? An intelligence platform that doesn’t just help you work smarter but actually also makes you smarter?  We are too.

BioMedGPS, the leader in online business intelligence for the Medical Device and Life Science industries, is seeking a Regenerative Medicine Analyst to support SmartTRAK Business Intelligence, an online, comprehensive, easy-to-use, web-based business intelligence solution used by the top 10 orthopedic implant companies and top 15 global wound care manufacturers. SmartTRAK integrates real time market data and analysis accessible throughout an organization, fostering an innovative collaborative approach to market strategy resulting in better decision-making.

We are looking for an experienced, motivated individual with expertise in the Regenerative Medicine market, with knowledge in one or more of the following areas:

SmartTRAK was the first real-time business intelligence portal for the Orthopedics, Wound Care and Neuro Therapies Markets. With SmartTRAK 3.0, arriving on August 6, 2018, you get all the same great content, tools and market coverage as before, but now in a more user friendly platform, where subscribers can more easily locate relevant information, enabling them to work quicker and more efficiently. You get fast, accurate, real-time information, in aggregate, available right at your fingertips, that ensures you will always be one step ahead of the competition.

In 2017, we asked some of our subscribers a simple question.

“How can we better help you?”

Our subscribers told us that they wanted easier access to information and usability. So, we rolled up our sleeves and got to work, calling on a user experience expert to help us streamline, overhaul and improve the experience for our users.

The result? SmartTRAK 3.0, featuring:

• Improved user experience: We made relevant business intelligence easier to get to and moved our most accessed information to our homepage.  Our navigation was greatly improved as was our search functionality, resulting in quicker digestion of pertinent intel for our users.